Liu et al. also demonstrated that heterozygous deletion of mouse chromosome 11B3, which corresponds to human 17p13.1, resulted in more aggressive lymphoma and leukemia than that produced by Trp53 deletion because of the combined effect of Trp53 loss and co-deletion of tumor suppressor genes in 11B3 [22]. This evidence concerns the gene TP53 and leukemia.